![Chas Pulido](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Chas Pulido
Fondatore presso
Alix Ventures
Profilo
Chas Pulido is the founder of Alix Ventures, which was founded in 2019.
He is currently an investor at Clora LLC, Mythic Therapeutics, Inc., Arc Care, Inc., Xilis, Inc., Elegen Corp., 64-X, Inc., Endpoint Health, Inc., Basil Systems, Inc., Teiko Bio, Inc., and Zafrens, Inc. He is also an advisor and first investor at Getlabs, Inc. and an advisor at Membio, Inc. Mr. Pulido received his undergraduate degree from the University of Notre Dame.
Posizioni attive di Chas Pulido
| Società | Posizione | Inizio |
|---|---|---|
Alix Ventures
 Alix Ventures Investment ManagersFinance Alix Ventures invests in companies located in the United states. The firm targets companies operating in the fields of health technology. It provides financing for early stage capital requirements. | Fondatore | 01/01/2019 |
Xilis, Inc.
 Xilis, Inc. Medical SpecialtiesHealth Technology Develops droplet-based microfluidics technology devices for precision cancer diagnostics and drug development | Investitore di Private Equity | 01/01/2020 |
Endpoint Health, Inc.
 Endpoint Health, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and builds biopharma and provides precision immunology therapies services | Investitore di Private Equity | 01/01/2022 |
Zafrens, Inc.
 Zafrens, Inc. BiotechnologyHealth Technology Develops tools and generates insights at interface of biology, chemistry, and engineering | Investitore di Private Equity | 01/01/2021 |
Mythic Therapeutics, Inc.
 Mythic Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops cancer therapeutics | Investitore di Private Equity | 01/01/2021 |
64-X, Inc.
 64-X, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which aims to engineer microbes that solve long-term problems | Investitore di Private Equity | 01/01/2021 |
Elegen Corp.
 Elegen Corp. BiotechnologyHealth Technology Operates as a biotechnology company that engages in synthesis activities for the production of DNA | Investitore di Private Equity | 01/01/2020 |
Getlabs, Inc.
 Getlabs, Inc. Internet Software/ServicesTechnology Services Operates as an online platform for home lab collections and diagnostics | Consulente / Consigliere | 01/01/2019 |
Teiko Bio, Inc.
 Teiko Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops an immune profiling platform that enables clinicians to make informed decisions around patient response | Investitore di Private Equity | 01/01/2021 |
| ░░░░░ ░░░ | ░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Formazione di Chas Pulido
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
1
Relazioni di 1° grado
14
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 14 |
|---|---|
University of Notre Dame
 University of Notre Dame Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Clora LLC
 Clora LLC Packaged SoftwareTechnology Services Develops intelligent platform that efficiently matches life science companies with flexible, on-demand expertise | Technology Services |
Mythic Therapeutics, Inc.
Mythic Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops cancer therapeutics | Health Technology |
Arc Care, Inc.
 Arc Care, Inc. Packaged SoftwareTechnology Services Develops and operates virtual health care platform | Technology Services |
Xilis, Inc.
Xilis, Inc. Medical SpecialtiesHealth Technology Develops droplet-based microfluidics technology devices for precision cancer diagnostics and drug development | Health Technology |
Alix Ventures
Alix Ventures Investment ManagersFinance Alix Ventures invests in companies located in the United states. The firm targets companies operating in the fields of health technology. It provides financing for early stage capital requirements. | Finance |
Elegen Corp.
Elegen Corp. BiotechnologyHealth Technology Operates as a biotechnology company that engages in synthesis activities for the production of DNA | Health Technology |
64-X, Inc.
64-X, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which aims to engineer microbes that solve long-term problems | Commercial Services |
Endpoint Health, Inc.
Endpoint Health, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and builds biopharma and provides precision immunology therapies services | Commercial Services |
Membio, Inc.
 Membio, Inc. BiotechnologyHealth Technology Manufactures bioreactor systems | Health Technology |
Getlabs, Inc.
Getlabs, Inc. Internet Software/ServicesTechnology Services Operates as an online platform for home lab collections and diagnostics | Technology Services |
Basil Systems, Inc.
 Basil Systems, Inc. Packaged SoftwareTechnology Services Develops AI platform for pharmaceutical and healthcare industries | Technology Services |
Teiko Bio, Inc.
Teiko Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops an immune profiling platform that enables clinicians to make informed decisions around patient response | Health Technology |
Zafrens, Inc.
Zafrens, Inc. BiotechnologyHealth Technology Develops tools and generates insights at interface of biology, chemistry, and engineering | Health Technology |
